Liquid biopsy as a prognostic and theranostic tool for the management of pancreatic ductal adenocarcinoma.
Abstract
Pancreatic ductal adenocarcinomas (PDAC) represent one of the deadliest cancers worldwide. Survival is still low due to diagnosis at an advanced stage and resistance to treatment. Herein, we review the main types of liquid biopsy able to help in both prognosis and adaptation of treatments.
Citations
Altmetric:
Date
2022-01-14
Type
Article
Other
Other
Subject
Surgery, Microbiology. Immunology, Gastroenterology
Collections
Citation
Osei-Bordom DC, Sachdeva G, Christou N. Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma. Front Med (Lausanne). 2022 Jan 14;8:788869. doi: 10.3389/fmed.2021.788869
Journal / Source Title
Frontiers in Medicine
DOI
10.3389/fmed.2021.788869
PMID
35096878
Publisher
Frontiers Media
Publisher’s URL
https://www.frontiersin.org/journals/medicine